When human platelets come in contact with fibrillar collagen, the platelets are stimulated to change shape, aggregate, and release the contents of their cytoplasmic granules into their extracellular surroundings. We have previously shown that antibodies directed against human plasma fibronectin produced in a goat and in rabbits are capable of stimulating the release ofserotonin from washed human platelets in vitro (1) . This finding, along with the isolation of fibronectin from a sonicated mixture ofplatelets and collagen and the inhibition ofcollageninduced platelet stimulation by fibronectin, led us to propose that platelet membrane fibronectin served as a collagen receptor.
The inability to visualize platelet surface fibronectin on fixed platelets by immunofluorescent methods (2, 3) and the failure of antifibronectin antibody Fab' fragments to totally abolish collagen-mediated platelet aggregation (4) suggested that platelet plasma membrane fibronectin, ifpresent at all, played at best a limited role in collagen-platelet interaction. These negative findings prompted speculation that antibody-induced serotonin secretion was caused by the presence of immune complexes in the incubation mixture (5) .
We originally suggested that immune complex formation was prevented in our experimental system by exhaustive washing ofthe isolated platelets (1). However, subsequent findings from other laboratories (6) (7) (8) have shown that fibronectin is a component of platelet a granules and therefore may be present in platelet preparations as a result ofplatelet lysis or degranulation resulting from preparative manipulation. These additional data thus suggest the possibility for an alterative interpretation ofour original observations in which release of serotonin from platelets as a result ofexposure to antifibronectin antibodies was due to immune complex formation mediated via the Fc receptor on the platelet surface (9, 10) .
The experiments reported here were designed to determine whether the stimulation ofplatelets by antifibronectin antibody was dependent on the Fc region ofthe antibody. In this report, we present evidence suggesting that serotonin release from platelets as a result of exposure to goat or rabbit antibodies directed against fibronectin requires that these antibodies retain their Fc regions. Furthermore, these results show that previous treatment of platelets with gelatin-Sepharose is insufficient to completely remove fibronectin from platelet preparations and that the remaining fibronectin is capable ofcombining with antibodies to form a stimulatory complex.
MATERIALS AND METHODS
Sepharose CL-4B and protein A were obtained from Pharmacia (Uppsala, Sweden). Rabbit anti-goat IgG antiserum was purchased from Miles. Gelatin, 300 Bloom, from swine skin was obtained from Sigma. Pepsin and papain were purchased from Worthington.
Blood was drawn from paid volunteers who denied ingestion ofany platelet-inhibitory substances for 2 wk prior to sampling. Platelets were isolated as described (1) and labeled by [3H]-serotonin (New England Nuclear) uptake prior to washing in incubation buffer (140 mM NaCl/0.3 mM EDTA/4 mM glucose/25 mM Tris-HC1, pH 7.4). The platelets were either washed once by centrifugation in this buffer for 10 min at 1,500 x g and 40C or gel filtered over affinity columns of covalently linked gelatin-Sepharose CL-4B. The washed or gel-filtered platelets were then suspended in incubation buffer to a final concentration of109/ml. All preparative and experimental steps involving the isolated platelets except the 1,500 X g washing were carried out at room temperature.
Preimmune IgGs from rabbit and goat sera were purified by Na2SO4 precipitation followed by DEAE-cellulose chromatography (11) . All purified antibodies were dialyzed against incubation buffer, divided into 1-mg aliquots, and stored at -70°C until use. Production of rabbit and goat antibodies against human plasma fibronectin and their purification by fibronectinSepharose affinity chromatography have been described (1) . F(ab')2 fragments were formed by limited proteolysis with pepsin at pH 4 for 16 hr (11 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
and purified by DEAE-cellulose chromatography, after a 16-hr papain digestion of preimmune goat IgG (11) . Immune and preimmune goat Fab' fragments were prepared by reduction with dithiothreitol and alkylation with iodoacetamide ofpepsinderived F(ab')2 fragments.
Undigested IgG was removed from F(ab')2 preparations in the following manner. The pepsin digest at pH 4 was neutralized by dialysis against incubation buffer and this neutralized solution was affinity chromatographed on columns of protein ASepharose. Nonadhering protein was collected and dialyzed at reduced pressure against incubation buffer overnight. Prior to use in experiments, all antibody and antibody fragment preparations were exhaustively dialyzed against incubation buffer.
Antifibronectin antibody and antibody fragments were mixed in appropriate amounts with 108 platelets, and platelet stimulation was measured by monitoring the release of [3H]serotonin (12) . All preincubation treatments and incubations were carried out for 15 min at room temperature. Antibody specificity was determined by Ouchterlony immunodiffusion, immunoelectrophoresis, or both, as described (1) . Antibody and antibody fragment concentrations were determined by UV extinction at 280 nm. Scintillation counting was carried out in formula 963 (New England Nuclear) in a Beckman DPM-1000 liquid scintillation spectrophotometer. RESULTS Effect of Fc Removal on Antifibronectin Antibody-Induced Platelet Stimulation. Platelets incubated for 15 min with rabbit or goat antifibronectin IgG released serotonin in a dose-dependent fashion. As shown in Fig. 1A , goat F(ab')2 is far less capable of stimulating platelets than whole goat antibody. The residual stimulatory capacity of the goat anti-human fibronectin F(ab')2 may be due to the presence in the preparation of undigested IgG belonging to an immunoglobulin subclass lacking affinity for staphylococcal protein A (11) . In contrast to goat IgG, however, rabbit IgG is completely digested to F(ab')2 by pepsin at Anti-human fibronectin, ,ug/ml Proc. Natl. Acad. Sci. USA 79 (1982) Proc. NatL Acad. Sci. USA 79 (1982) 6539 pH 4 (11). The F(ab')2 preparation from rabbit anti-human fibronectin antibody totally lacks the ability to stimulate platelets at F(ab')2 doses as high as 300 ,ug/ml (Fig. LB) .
The severely reduced or complete lack of ability of goat or rabbit anti-human fibronectin F(ab')2 fragments to stimulate platelets in a manner similar to the whole antibody molecules suggests that this serotonin release is mediated by the Fc region of the whole antibody molecules. The inability of preimmune IgG to elicit serotonin release has been documented previously (1) were used at 100 ug/ml. ous treatment of the platelets with gelatin/Sepharose did not affect their ability to be stimulated by antifibronectin antibody. This implies that the antigenic fibronectin associated with the platelets is tightly bound yet capable of forming immune complexes that can lead to the release of granule contents. DISCUSSION Fibronectin is a glycoprotein that has been implicated as an intermediate in the attachment of cells ofwidely divergent functions to collagen (13) . We have previously presented evidence (1) that platelet fibronectin may function as a collagen receptor on the platelet plasma membrane. First, when platelets were attached to collagen, sonicated, and washed, the material adhering to the collagen contained a glycoprotein that comigrated with fibronectin on NaDodSO4/polyacrylamide gels. Second, the collagen-attached material contained a protein that reacted with antifibronectin antibody by immunoelectrophoresis. Third, when fibronectin that had been incubated with fibrous collagen was used, the collagen-platelet interaction was inhibited. Fourth, a protein extracted from washed platelets and isolated Cell Biology: Holderbaum et al on antifibronectin affinity columns was shown to bind fibrous collagen. Based on these findings, we proposed that fibronectin on the platelet plasma membrane could serve as a collagen binding site on these cells.
For fibronectin to act as a collagen receptor of platelets, the molecule must be present on the cell surface of intact cells. Attempts to visualize fibronectin on fixed platelets by immunochemical methods failed to provide evidence that fibronectin is a normal constituent of the platelet plasma membrane (2, 3, 14) . In this report, we have demonstrated that extensive washing or previous treatment with gelatin-Sepharose of platelets does not diminish their ability to be stimulated by antifibronectin antibody. Thus, extracellular fibronectin associated with these platelet preparations must either be a part of the plasma membrane or tightly associated with it. We have shown that platelets from certain donors do not respond to antifibronectin antibody by release ofserotonin (15) . This donor incompatibility may explain the failure of other investigators to detect fibronectin in intact platelet preparations by immunocytochemical methods.
We originally postulated that plasma membrane fibronectin acted as a receptor for collagen and, when in contact with fibrillar collagen, acted as a message transducer in the sequence of events leading to platelet degranulation. We believed that antifibronectin antibody interacted with this membrane-bound fibronectin in a manner similar to collagen. Ifthis were the case, then antifibronectin F(ab')2 should induce release of serotonin from platelets in the same fashion as does whole antibody. Instead, antifibronectin F(ab')2 from either goat or rabbit sources was incapable of eliciting release. Furthermore, previous incubation of the platelets with either preimmune IgG or equivalent concentrations of purified Fc inhibited antibody-induced release.
These findings, combined with the finding that F(ab')2 as a second antibody does not induce stimulation, suggest that formation of the immune complex is required for platelet stimulation by antifibronectin IgG. Immune complexes are known to induce release ofserotonin from platelets (9, 10) and the findings reported here are consistent with this mechanism ofplatelet stimulation.
The origin of the fibronectin acting as an antigen in these experiments is not known. We do not feel, however, that plasma fibronectin is a likely candidate. The washing or gelatin-Sepharose treatment of the platelets should remove essentially all of this material. Fibronectin is known to be present in platelet a granules (6). Since we always observe a basal level of extracellular serotonin comprising 5-10% ofthe total in the unstimulated preparations, it is probable that some degranulation of cells during preparative steps is unavoidable. If this is the case, then extracellular fibronectin of platelet origin might serve as the antigen resulting in stimulatory complex formation.
These results show that, if fibronectin is present on platelet plasma membrane, it is incapable of interacting with immune F(ab')2 fragments in a manner that promotes release ofserotonin from platelets. This dependence on the Fc receptor for stimulation by antifibronectin antibody suggests that plasma membrane fibronectin is unlikely to play an integral part in antibodyinduced stimulation.
